Carcinogenesis, Teratogenesis & Mutagenesis ›› 2017, Vol. 29 ›› Issue (1): 42-45,50.doi: 10.3969/j.issn.1004-616x.2017.01.008

Previous Articles     Next Articles

Analysis of DNA methylation during BaP-induced malignant transformation in vitro

LIU Hailong1,2, GAO Wei1, GU Pan1, DENG Yanxia1, HUANG Xinfeng1, WU Desheng1, LIU Jianjun1, HUANG Haiyan1   

  1. 1. Key Laboratory of Modern Toxicology of Shenzhen, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, Guangdong;
    2. School of Public Health, Nanchang University, Nanchang 330031, Jiangxi, China
  • Received:2016-07-08 Revised:2016-11-02 Online:2017-01-31 Published:2017-01-31

Abstract:

OBJECTIVE: To investigate the role of DNA methylation as a possible mechanism of Benzo[a]pyrene (BaP) induction of malignant transformation in vitro. METHODS: Human bronchial epithelial cells (16HBE cell line) were treated with different concentrations BaP (0,10,20 and 40 μmol/L) for 1,9 and 15 weeks. Then,5-methylcytosine immunofluorescent assay was used to detect genomic DNA methylation level,Western blotting and RT-PCR were used to detect protein and mRNA levels of DNMT1,DNMT3a,DNMT3b and MBD2. RESULTS: BaP treatment decreased expression of 5-mC (methylation) in 16HBE cells in a dose- and time-dependent manner. The protein and mRNA levels of DNMT1 showed in a significant dose- and time-dependent reduction (P < 0.05),but there were no signi fi-cant changes in protein levels of DNMT3a,DNMT3b and MBD2(all P > 0.05). CONCLUSION: BaP treatment decreased the global DNA methylation levels in 16HBE cells and reduction of DNMT1 expression could play an important role.

Key words: benzo[a]pyrene, DNA methylation, malignant transformation

CLC Number: